IRWD — Ironwood Pharmaceuticals Inc · P/E 5.7, rev $219.5M

Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Latest reported IRWD revenue for 2026-06-30 was $219.5M. Net income was $92.1M. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.

Use this IRWD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IRWD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IRWD SEC filings page. Lician reads the product cache first so this HTML stays unique to Ironwood Pharmaceuticals Inc even when a live quote feed is slow.

Ironwood Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full IRWD income, balance, and cash tables.

  • Revenue$47.7M
  • Net Income-$2.3M
  • Total Assets$396.9M
  • Total Debt$0
  • Free Cash Flow$127.0M

IRWD recent filings